D.E. Shaw & Co

D.E. Shaw & Co’s CRISPR Therapeutics CRSP Stock Holding History

D.E. Shaw & Co’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,200	Closed	-$1.58M	–	4623
2025 Q4	$1.58M	Sell	30,200 -40,000	-57%	-$2.4M	﹤0.01%	3226
2025 Q3	$4.55M	Buy	+70,200	New	+$4.03M	﹤0.01%	2311
2024 Q4	–	Sell	-35,500	Closed	-$1.67M	–	4472
2024 Q3	$1.67M	Buy	35,500 +24,000	+209%	+$1.22M	﹤0.01%	2854
2024 Q2	$621K	Sell	11,500 -1,600	-12%	-$92.5K	﹤0.01%	3493
2024 Q1	$893K	Sell	13,100 -73,200	-85%	-$5.24M	﹤0.01%	3163
2023 Q4	$5.4M	Buy	86,300 +76,300	+763%	+$4.22M	﹤0.01%	1847
2023 Q3	$454K	Hold	10,000	–	–	﹤0.01%	3464
2023 Q2	$561K	Sell	10,000 -20,000	-67%	-$1.13M	﹤0.01%	3375
2023 Q1	$1.36M	Sell	30,000 -70,000	-70%	-$3.4M	﹤0.01%	2950
2022 Q4	$4.07M	Buy	100,000 +40,000	+67%	+$2.12M	﹤0.01%	2290
2022 Q3	$3.92M	Sell	60,000 -30,000	-33%	-$2.17M	﹤0.01%	2357
2022 Q2	$5.47M	Sell	90,000 -40,000	-31%	-$2.35M	0.01%	2014
2022 Q1	$8.16M	Buy	130,000 +60,000	+86%	+$3.77M	0.01%	1799
2021 Q4	$5.3M	Buy	70,000 +56,000	+400%	+$4.89M	﹤0.01%	2304
2021 Q3	$1.57M	Sell	14,000 -50,000	-78%	-$6.28M	﹤0.01%	3235
2021 Q2	$10.4M	Sell	64,000 -61,500	-49%	-$7.48M	0.01%	1468
2021 Q1	$15.3M	Buy	+125,500	New	+$19M	0.01%	1094
2020 Q4	–	Sell	-20,000	Closed	-$1.67M	–	3953
2020 Q3	$1.67M	Hold	20,000	–	–	﹤0.01%	2519
2020 Q2	$1.47M	Buy	+20,000	New	+$1.17M	﹤0.01%	2648
2019 Q1	–	Sell	-30,000	Closed	-$857K	–	3643
2018 Q4	$857K	Buy	+30,000	New	+$1.04M	﹤0.01%	2758

Other funds holding CRSP

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GSK plc London $599M AUM

T. Rowe Price Investment Management

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return